Redox/NIR dual-responsive glutathione extended polyurethane urea electrospun membranes for synergistic chemo-photothermal therapy
Despite advancements in cancer treatments, therapies frequently exhibit high cytotoxicity, and surgery remains the predominant method for treating most solid tumors, often with limited success in preventing post-surgical recurrence. Implantable biomaterials, designed to release drugs at a localised site in response to specific stimuli, represent a promising approach for enhancing tumour therapy. In this study, a redox-responsive glutathione extended polyurethane urea (PolyCEGS) was used to produce paclitaxel (PTX) and gold nanorods (AuNRs) loaded electrospun membranes for combined redox/near-infrared (NIR) light-responsive release chemotherapy and hyperthermic effect. Electrospinning conditions were optimized to fabricate AuNR-loaded scaffolds, at three different AuNRs concentrations. The obtained membranes were characterized by scanning electron microscopy (SEM) analyses and photothermal profiles were evaluated by a thermocamera, showing a temperature increase, up to 42.5 °C, when exposed to NIR light (810 nm) at 3 W/cm<sup>2</sup>. The AuNRs/PTX loaded scaffolds exhibited sustained PTX release, with 15 % released over 30 days and almost 1.8 times more in a simulated reductive environment. Moreover, their excellent photothermal effects and NIR light-triggered release led to significant synergic cytotoxicity in human colon cancer (HCT-116) and human breast cancer (MCF-7) cell lines. This system potentially enables controllable locoregional PTX release at the tumour site post-surgery, preventing recurrence and enhancing cytotoxicity through combined drug and PTT effects, highlighting its potential for future anticancer treatments.
Authors
- Giovanna Pitarresi (ORCID: https://orcid.org/0000-0002-0815-9142)
- Maurizio Marrale
- Francesco Cancilla (ORCID: https://orcid.org/0000-0002-8453-0804)
- Giovanni Carlo Miceli (ORCID: https://orcid.org/0000-0002-1895-8343)
- Mariano Licciardi (ORCID: https://orcid.org/0000-0003-4539-9337)
- Luigi Tranchina (ORCID: https://orcid.org/0000-0001-5608-3114)
- Giorgia Puleo (ORCID: https://orcid.org/0000-0002-1828-0157)
- Fabio Salvatore Palumbo (ORCID: https://orcid.org/0000-0001-6196-7782)
- Annalisa Martorana (ORCID: https://orcid.org/0000-0002-5307-2476)
Institutions
- Institute for Biomedical Research and Innovation (IT)
- Ri.MED (IT)
- Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IT)
- University of Palermo (IT)
Publication Details
- Journal
- International Journal of Pharmaceutics
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1016/j.ijpharm.2024.125108
- Citations
- 15
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.77
Funders
- Villum Fonden
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Novo Nordisk Fonden